Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer

Anniina Färkkilä, Doga C. Gulhan, Julia Casado, Connor A. Jacobson, Huy Nguyen, Bose Kochupurakkal, Zoltan Maliga, Clarence Yapp, Yu-An Chen, Denis Schapiro, Yinghui Zhou, Julie R. Graham, Bruce J. Dezube, Pamela Munster, Sandro Santagata, Elizabeth Garcia, Scott Rodig, Ana Lako, Dipanjan Chowdhury, Geoffrey ShapiroUrsula A. Matulonis, Peter J. Park, Sampsa Hautaniemi, Peter K. Sorger, Elizabeth M. Swisher, Alan D. D'Andrea, Panagiotis A. Konstantinopoulos

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number1459
JournalNature Communications
Volume11
Issue number1
Number of pages13
ISSN2041-1723
DOIs
Publication statusPublished - 19 Mar 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • GENOMIC INSTABILITY
  • PEMBROLIZUMAB
  • EXPRESSION
  • THERAPY
  • BREAST
  • 3122 Cancers
  • 1184 Genetics, developmental biology, physiology

Activities

  • 1 Academic visit to other institution

Harvard Medical School, Harvard University

Julia Casado (Visiting researcher)

15 Sep 201820 Dec 2018

Activity: Visiting an external institution typesAcademic visit to other institution

Cite this

Färkkilä, A., Gulhan, D. C., Casado, J., Jacobson, C. A., Nguyen, H., Kochupurakkal, B., Maliga, Z., Yapp, C., Chen, Y-A., Schapiro, D., Zhou, Y., Graham, J. R., Dezube, B. J., Munster, P., Santagata, S., Garcia, E., Rodig, S., Lako, A., Chowdhury, D., ... Konstantinopoulos, P. A. (2020). Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer. Nature Communications, 11(1), [1459]. https://doi.org/10.1038/s41467-020-15315-8